FRM
GCVRZ

Fore Research & Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Fore Research & Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-192,037
Closed -$36K – 49
2015
Q3 		$36K Hold
192,037
– – ﹤0.01% 41
2015
Q2 		$134K Hold
192,037
– – ﹤0.01% 52
2015
Q1 		$130K Hold
192,037
– – ﹤0.01% 40
2014
Q4 		$151K Hold
192,037
– – 0.01% 39
2014
Q3 		$89K Hold
192,037
– – ﹤0.01% 49
2014
Q2 		$96K Sell
192,037
-50,000
-21% -$24.2K ﹤0.01% 63
2014
Q1 		$75K Buy
242,037
+92,037
+61% +$34.2K ﹤0.01% 89
2013
Q4 		$51K Buy
+150,000
New +$181K ﹤0.01% 59

Other funds holding GCVRZ

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Fore Research & Management's GCVRZ Position: Q4 2015 in Review

Fore Research & Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2015, closing a stake of 192,037 shares — an estimated $36K sold.

Fore Research & Management first reported a position in GCVRZ in Q4 2013 and held it in 8 quarters. The position peaked at $151K in Q4 2014. 114 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2015.

  • Fore Research & Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
  • Fore Research & Management sold 192,037 Sanofi Contingent Value Rights shares in Q4 2015, an estimated $36K.
  • Fore Research & Management first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 8 quarters.
  • Fore Research & Management's Sanofi Contingent Value Rights position peaked at $151K in Q4 2014.
  • 114 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2015.

Based on Fore Research & Management's 13F filing for Q4 2015, filed 16 Feb 2016.